Clinical assessment of levamlodipine besylate combination therapy for essential hypertension: A protocol for systematic review and meta-analysis

BACKGROUND: Essential hypertension has been regarded a significant risk factor for cardiovascular disease across the globe, and a significant escapable causation of early death as well as morbidity in the U.S. When angiotensin II receptor blockers and calcium channel blockers are used to treat essen...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Guo-Yao, Zhu, Ye-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
5200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276456/
https://www.ncbi.nlm.nih.gov/pubmed/35421067
http://dx.doi.org/10.1097/MD.0000000000029148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276456/
https://www.ncbi.nlm.nih.gov/pubmed/35421067
http://dx.doi.org/10.1097/MD.0000000000029148

Ejemplares similares